Arkadios Wealth Advisors increased its holdings in shares of Danaher Co. (NYSE:DHR – Get Rating) by 2.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,155 shares of the conglomerate’s stock after buying an additional 115 shares during the period. Arkadios Wealth Advisors’ holdings in Danaher were worth $1,053,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. GHP Investment Advisors Inc. acquired a new stake in Danaher during the 1st quarter worth approximately $26,000. Lloyd Advisory Services LLC. acquired a new position in shares of Danaher in the 1st quarter worth approximately $26,000. Landmark Wealth Management LLC acquired a new position in shares of Danaher in the 1st quarter worth approximately $32,000. Lansing Street Advisors acquired a new position in shares of Danaher in the 1st quarter worth approximately $34,000. Finally, American National Bank acquired a new position in shares of Danaher in the 1st quarter worth approximately $35,000. 77.27% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
DHR has been the topic of a number of recent analyst reports. Credit Suisse Group initiated coverage on shares of Danaher in a research report on Wednesday, August 24th. They issued an “outperform” rating and a $340.00 price target on the stock. Evercore ISI dropped their price target on shares of Danaher from $320.00 to $280.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 5th. Sanford C. Bernstein began coverage on shares of Danaher in a research report on Tuesday, August 16th. They issued an “outperform” rating and a $340.00 price target on the stock. Robert W. Baird lifted their price objective on shares of Danaher from $319.00 to $325.00 in a research note on Friday, July 22nd. Finally, Benchmark lowered their price objective on shares of Danaher from $345.00 to $325.00 and set a “buy” rating for the company in a research note on Tuesday. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Danaher presently has an average rating of “Buy” and an average price target of $321.75.
Insider Transactions at Danaher
Danaher Stock Performance
Shares of DHR stock opened at $266.43 on Friday. The firm has a market capitalization of $193.81 billion, a PE ratio of 31.38, a price-to-earnings-growth ratio of 1.29 and a beta of 0.88. The firm has a fifty day simple moving average of $280.99 and a two-hundred day simple moving average of $269.91. The company has a current ratio of 1.75, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. Danaher Co. has a 12 month low of $233.71 and a 12 month high of $331.68.
Danaher (NYSE:DHR – Get Rating) last announced its quarterly earnings results on Thursday, July 21st. The conglomerate reported $2.76 EPS for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. Danaher had a net margin of 20.61% and a return on equity of 18.57%. The business had revenue of $7.75 billion during the quarter, compared to analyst estimates of $7.29 billion. During the same quarter in the previous year, the business posted $2.46 EPS. Danaher’s quarterly revenue was up 7.4% on a year-over-year basis. Analysts forecast that Danaher Co. will post 10.4 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be paid a $0.25 dividend. The ex-dividend date is Thursday, September 29th. This represents a $1.00 annualized dividend and a dividend yield of 0.38%. Danaher’s payout ratio is 11.78%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.